吉利德公司和 Arcus 公司放弃抗癌药物组合的后期试验

路透中文
Dec 12, 2025
<a href="https://laohu8.com/S/00175">吉利</a>德公司和 Arcus 公司放弃抗癌药物组合的后期试验

路透12月12日 - 吉利德科学公司(Gilead Sciences GILD.O)和Arcus生物科学公司(Arcus Biosciences RCUS.N)周五表示,他们将停止一项晚期研究,该研究将对晚期胃癌和食管癌患者进行试验性抗癌药物联合治疗,因为该研究未能显示出生存获益。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10